Literature DB >> 23940230

Explicit prognostic information and reassurance about nonabandonment when entering palliative breast cancer care: findings from a scripted video-vignette study.

Liesbeth M van Vliet1, Elsken van der Wall, Nicole M Plum, Jozien M Bensing.   

Abstract

PURPOSE: When discussing the transition to palliative care for patients with breast cancer, oncologists have to find a balance between giving explicit information while not overwhelming patients and being realistic while remaining hopeful. It is unclear whether patients prefer more or less explicit prognostic information, and reassuring patients that they will not be abandoned may provide realistic hope. We assessed the effect of explicit prognostic information and reassurance about nonabandonment at the transition to palliative care. PATIENTS AND METHODS: An experimental 2 × 2 study was used. Four scripted videos of a bad news conversation were created that differed only in the level of "explicitness of prognosis" and "reassurance about nonabandonment" (high v low). Patients with and survivors of breast cancer (n = 51) and healthy women (n = 53) watched the video-vignettes. The effects of the different communications on participants' anxiety, uncertainty, self-efficacy, and satisfaction were assessed by using multilevel analyses that explored the moderating influences of monitoring/blunting scores.
RESULTS: The highly explicit/highly reassuring video yielded the most positive outcomes, and the less explicit/less reassuring video, the most negative (P ≤ .05 for all outcome measures except anxiety). The main effects found were that explicitness and reassurance decreased participants' uncertainty (P < .001 and P = .002, respectively) and anxiety (only after reassurance; P = .001) while increasing self-efficacy (P = .004 and P < .001, respectively) and satisfaction (P < .001 and P < .001, respectively). High monitors seemed least positive, mainly following explicitness.
CONCLUSION: Explicit prognostic information may lead to better outcomes than general information. In addition, reassurance about nonabandonment might provide realistic hope but should be lived up to. More research is needed to translate these findings into clinical care.

Entities:  

Mesh:

Year:  2013        PMID: 23940230     DOI: 10.1200/JCO.2012.45.5865

Source DB:  PubMed          Journal:  J Clin Oncol        ISSN: 0732-183X            Impact factor:   44.544


  18 in total

1.  Handling uncertainty.

Authors:  Lidia Schapira
Journal:  Support Care Cancer       Date:  2013-12-17       Impact factor: 3.603

2.  Commentary: "the Lake Wobegon effect, a natural human tendency to overestimate one's capabilities" (Wikipedia).

Authors:  Thomas J Smith
Journal:  Milbank Q       Date:  2013-12       Impact factor: 4.911

Review 3.  Current state of the art and science of patient-clinician communication in progressive disease: patients' need to know and need to feel known.

Authors:  Liesbeth M van Vliet; Andrew S Epstein
Journal:  J Clin Oncol       Date:  2014-09-29       Impact factor: 44.544

4.  Obtaining Helpful Information From the Internet About Prognosis in Advanced Cancer.

Authors:  Ivan Chik; Thomas J Smith
Journal:  J Oncol Pract       Date:  2015-07       Impact factor: 3.840

5.  Adding a Wider Range and "Hope for the Best, and Prepare for the Worst" Statement: Preferences of Patients with Cancer for Prognostic Communication.

Authors:  Masanori Mori; Maiko Fujimori; Hiroto Ishiki; Tomohiro Nishi; Jun Hamano; Hiroyuki Otani; Yu Uneno; Akira Oba; Tatsuya Morita; Yosuke Uchitomi
Journal:  Oncologist       Date:  2019-02-19

6.  Neurologic Outcome After Prematurity: Perspectives of Parents and Clinicians.

Authors:  Monica E Lemmon; Hanna Huffstetler; Mary Carol Barks; Christine Kirby; Madelaine Katz; Peter A Ubel; Sharron L Docherty; Debra Brandon
Journal:  Pediatrics       Date:  2019-07       Impact factor: 7.124

7.  AMEN in challenging conversations: bridging the gaps between faith, hope, and medicine.

Authors:  Rhonda S Cooper; Anna Ferguson; Joann N Bodurtha; Thomas J Smith
Journal:  J Oncol Pract       Date:  2014-05-06       Impact factor: 3.840

8.  Systemic Therapy for Stage IV Non-Small-Cell Lung Cancer: American Society of Clinical Oncology Clinical Practice Guideline Update.

Authors:  Gregory A Masters; Sarah Temin; Christopher G Azzoli; Giuseppe Giaccone; Sherman Baker; Julie R Brahmer; Peter M Ellis; Ajeet Gajra; Nancy Rackear; Joan H Schiller; Thomas J Smith; John R Strawn; David Trent; David H Johnson
Journal:  J Clin Oncol       Date:  2015-08-31       Impact factor: 44.544

Review 9.  The Importance of Prognostication: Impact of Prognostic Predictions, Disclosures, Awareness, and Acceptance on Patient Outcomes.

Authors:  David Hui; Li Mo; Carlos Eduardo Paiva
Journal:  Curr Treat Options Oncol       Date:  2021-01-11

10.  Patients' and Clinicians' Perceptions of Clinician-Expressed Empathy in Advanced Cancer Consultations and Associations with Patient Outcomes.

Authors:  Hinke Hoffstädt; Jacqueline Stouthard; Maartje C Meijers; Janine Westendorp; Inge Henselmans; Peter Spreeuwenberg; Paul de Jong; Sandra van Dulmen; Liesbeth M van Vliet
Journal:  Palliat Med Rep       Date:  2020-06-11
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.